Unlock document.
This document is partially blurred.
Unlock all pages and 1 million more documents.
Get Access
Kimberly-Clark; Does a tissue by any other name smell as sweet?
By: Krystal Holmes
Kimberly Clark, believe it or not, is a household name; especially this time of year. However, you
may know them as, simply, the makers of Kleenex. This paper and personal products giant has been
around since 1872 and has been publically traded on the New York Stock Exchange since 1929 under the
ticker symbol KMB. It has been on the Fortune 500 list for 24 years, and currently ranks number 163 on
that list. The information available for this company on the internet is massive, in-depth, and widely
available. All of this makes it a wonderful candidate for analysis purposes. What is not widely available
however, is a consensus on this stock.
Kimberly Clark as a company is not what I would call promising, it does appear to be stable though. They
currently have a bullish rating by NASDAQ, which sounds promising, however they have had very slow
growth over the last 10 years, which is not very promising. Like the statistics available, the opinions on
this stock are quite contradictory. Investor’s Business Daily (5) says it is worth buying as its relative
strength rating just increased to 82 points. They assert that this is a good sign, as all companies who
experience a large run of good stock prices started with a rating over 80. That being said, not all
companies with a rating over 80 experience a large run. Another source said it was a hold stock, worth
keeping if you have it but not worth buying at this time. The Motley Fool (4) feels it is not worth buying
at all, quoting slow growth, a trading price that is 23 times earnings, and what they called a low dividend
